What's new

Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 17, Status: Authorised

Feb 13, 2025 - 10:51
 0
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

ANA InterContinental Tokyo unveils Icon Reborn transformation

Next Article

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,dr...

Related Posts

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza Te, vaccine against equine influenza and tetanus in horses, Status: Authorised

Veterinary medicines European public assessment report ...

Mar 7, 2025  0

New product information wording: extracts from PRAC rec...

Apr 7, 2025  0

Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 16, 2025  0